[T.S.R:14509] Kredent Research Desk Parabolic Drugs Limited_IPO Note

 

Dear All,

Please find attached below the IPO note on Parabolic Drugs Limited.

The Company is presently engaged in the business of Manufacturing Active Pharmaceutical Ingredients (APIs) and API intermediates for the domestic market as well as for exports to international markets. The company on its price band trades commands a higher valuation compared to its peers which does not seem justified. Considering the inherent risks associated with the operations of the company and the relative underperformance compared to its peers we recommend investors to "Avoid" this issue 

                                            

Hope this is useful.

 

Regards,

 

Kredent Research Desk